drugset / Trial / NCT00441051

Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn

NCT00441051

Phase 3 Completed 45 enrolled Novartis
RandomizedSingle-groupDouble-blindTreatment

Summary

Diclofenac sodium 0.1% will be applied to sunburned skin when the intensity of pain reaches a certain level in order to evaluate the efficacy and safety of the treatment on this induced pain.

Timeline

Start
2006-11
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 0.1 % Topical

Indications